We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$211M
AUM Growth
+$4.37M
Cap. Flow
-$6.46M
Cap. Flow %
-3.07%
Top 10 Hldgs %
31.01%
Holding
69
New
12
Increased
18
Reduced
24
Closed
9

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$6.79M
2
UNH icon
UnitedHealth
UNH
+$5.84M
3
TMO icon
Thermo Fisher Scientific
TMO
+$4.67M
4
HCA icon
HCA Healthcare
HCA
+$3.84M
5
ELV icon
Elevance Health
ELV
+$3.44M

Top Sells

Rank Stock Value
1
HNT
HEALTH NET INC
HNT
+$6.31M
2
GILD icon
Gilead Sciences
GILD
+$5.4M
3
CVS icon
CVS Health
CVS
+$5.31M
4
HUM icon
Humana
HUM
+$5.26M
5
CI icon
Cigna
CI
+$4.81M

Sector Composition

Rank Sector Weight
1 Healthcare 87.1%
2 Financials 2.57%
3 Energy 1.89%
4 Industrials 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
1
HCA Healthcare
HCA
$88B
$9.47M 4.5%
140,000
+55,000
+65% +$3.84M
UHS icon
2
Universal Health Services
UHS
$10.2B
$7.77M 3.69%
65,000
+22,778
+54% +$2.78M
CAH icon
3
Cardinal Health
CAH
$55.2B
$7.14M 3.39%
+80,000
New +$6.79M
AMGN icon
4
Amgen
AMGN
$204B
$6.49M 3.08%
40,000
– –
TEVA icon
5
Teva Pharmaceuticals
TEVA
$40.2B
$5.97M 2.84%
91,000
+11,600
+15% +$717K
UNH icon
6
UnitedHealth
UNH
$377B
$5.88M 2.79%
+50,000
New +$5.84M
CI icon
7
Cigna
CI
$74.5B
$5.85M 2.78%
40,000
-35,000
-47% -$4.81M
ALXN
8
DELISTED
Alexion Pharmaceuticals
ALXN
$5.72M 2.72%
30,000
+5,000
+20% +$873K
BSX icon
9
Boston Scientific
BSX
$70.2B
$5.53M 2.63%
300,000
+150,000
+100% +$2.69M
AGN
10
DELISTED
Allergan plc
AGN
$5.47M 2.6%
17,500
-2,500
-13% -$744K
AET
11
DELISTED
Aetna Inc
AET
$5.41M 2.57%
50,000
-30,000
-38% -$3.24M
BMY icon
12
Bristol-Myers Squibb
BMY
$134B
$5.16M 2.45%
75,000
– –
TMO icon
13
Thermo Fisher Scientific
TMO
$212B
$4.96M 2.36%
+35,000
New +$4.67M
MCK icon
14
McKesson
MCK
$96.8B
$4.93M 2.34%
25,000
-20,000
-44% -$3.78M
VTRS icon
15
Viatris
VTRS
$20.5B
$4.87M 2.31%
90,000
+30,000
+50% +$1.44M
CELG
16
DELISTED
Celgene Corp
CELG
$4.79M 2.27%
40,000
-10,000
-20% -$1.16M
CYH icon
17
Community Health Systems
CYH
$412M
$4.38M 2.08%
199,529
+52,316
+36% +$1.35M
HNT
18
DELISTED
HEALTH NET INC
HNT
$4.22M 2%
61,579
-98,421
-62% -$6.31M
RAD
19
DELISTED
Rite Aid Corporation
RAD
$4.19M 1.99%
26,750
-10,750
-29% -$1.59M
LHCG
20
DELISTED
LHC Group LLC
LHCG
$3.97M 1.89%
87,705
+20,000
+30% +$914K
BIIB icon
21
Biogen
BIIB
$29.8B
$3.83M 1.82%
12,500
-7,500
-38% -$2.16M
THC icon
22
Tenet Healthcare
THC
$20.1B
$3.79M 1.8%
125,000
+62,555
+100% +$2.05M
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$119B
$3.77M 1.79%
30,000
-10,000
-25% -$1.21M
CHE icon
24
Chemed
CHE
$7.07B
$3.75M 1.78%
25,000
+9,004
+56% +$1.33M
HUM icon
25
Humana
HUM
$45B
$3.57M 1.7%
20,000
-30,000
-60% -$5.26M
1
2 3

Similar funds

RSF
Rik Saylor Financial Fairfield, Ohio $132M AUM 16.04% 1-Year Est. Return
VF
Visa Foundation San Francisco, California $132M AUM 14.62% 1-Year Est. Return
AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
DQRIM
Dale Q Rice Investment Management Vancouver, Washington $132M AUM 45.8% 1-Year Est. Return

Sivik Global Healthcare's Q4 2015 Portfolio in Review

As of Q4 2015, Sivik Global Healthcare held 69 positions worth $211M, up 2.1% from $206M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Sivik Global Healthcare withdrew a net $6.46M in Q4 2015, closing 9 positions and reducing 24 holdings. Its most notable exit was Gilead Sciences, an estimated $5.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 84% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in Cardinal Health worth $7.14M.

  • Sivik Global Healthcare's largest Q4 2015 buy was Cardinal Health: 80,000 shares worth $7.14M.
  • Sivik Global Healthcare added most to HCA Healthcare in Q4 2015, an estimated $3.84M increase.
  • Sivik Global Healthcare's biggest Q4 2015 reduction was HEALTH NET INC, cutting an estimated $6.31M.
  • Sivik Global Healthcare fully exited Gilead Sciences in Q4 2015, selling an estimated $5.4M.
  • Sivik Global Healthcare's ten largest holdings make up 31% of its $211M portfolio in Q4 2015.
  • Sivik Global Healthcare opened 12 new positions and closed 9 in Q4 2015.
  • Sivik Global Healthcare's portfolio value rose 2.1% quarter-over-quarter to $211M.

Based on Sivik Global Healthcare's 13F filing for Q4 2015, filed 5 Feb 2016.